Perioperative coagulation management and control of platelet transfusion by point-of-care platelet function analysis

Transfusion Medicine and Hemotherapy

Volumn 34, Issue 6, 2007, Pages 396-411

  Gorlinger K ^a   Jambor, C ^b   Hanke, A A ^a   Dirkmann, D ^a   Adamzik, M ^a   Hartmann, M ^a   Rahe Meyer, N ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cardiac surgery; Impedance aggregometry; Platelet function analysis; Point of care coagulation management; Thrombelastometry

Indexed keywords

ALGORITHM; ANALYZER; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; COST EFFECTIVENESS ANALYSIS; HEART SURGERY; HUMAN; MONITORING; PERIOPERATIVE PERIOD; POINT OF CARE TESTING; QUESTIONNAIRE; REVIEW; STANDARD; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY;

EID: 37049026661     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109642     Document Type: Review

References (139)

1. Levy JH, Tanaka KA, Steiner ME: Evaluation and management of bleeding during cardiac surgery. Curr Hematol Rep 2005;4:368-372.
2. Despotis GJ, Goodnough LT: Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery. Ann Thorac Surg 2000;70(suppl):S20-S32.
3. Calatzis A, Heesen M, Spannagl M: Patientennahe Sofortdiagnostik von Hämostasestörungen in der Anästhesie und Intensivmedizin. Anaesthesist 2003;52:229-237.
4. Sié P, Steib A: Central laboratory and point of care assessment of perioperative hemostasis. Can J Anest 2006;53(suppl):S12-S20.
5. Despotis GJ, Skubas NJ, Goodnough LT: Optimal management of bleeding and transfusion in patients undergoing cardiac surgery. Semin Thorac Cardiovasc Surg 1999;11:84-104.
6. Goodnough LT, Despotis GJ: Future directions in utilization review: the role of transfusion algorithms. Transfus Sci 1998;19:97-105.
7. Görlinger K, Dirkmann D, Hanke AA, Adamzik M, Peters J: Inpact of ROTEM®-based coagulation management on usage of blood components and cost saving in LTX. Anesthesiology 2007;107:A2124.
8. Karkouti K, Wijeysundera DN, Yau TM, Beattie WS, Abdelnaem E, McCluskey SA, Ghannam M, Yeo E, Djaiani G, Karski J: The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004;44:1453-1462.
9. Dzik S: Non-infectious serious hazards of transfusion. Blood Bull 2002;5:1-2.
10. Gajic O, Gropper MA, Hubmayr RD: Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med 2006;34(suppl):S109-S113.
11. Hambly PR, Dutton RP: Excess mortality associated with the use of a rapid infusion system at a level 1 trauma center. Resuscitation 1996;31:127-133.
12. Popovsky MA: Pulmonary consequences of transfusion: TRALI and TACO. Transfus Apher Sci 2006;34:243-244.
13. SHOT Annual Report 2005: Serious hazards of transfusion. www.shotuk.org/SHOT%20report%202005.pdf.
14. Wallis JP, Dzik S: Is fresh frozen plasma overtransfused in the United States? Transfusion 2004;44:1674-1675.
15. Spiess BD: Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothorac Vasc Anesth 2004;8:267-281.
16. Spiess BD, Royston D, Levy JH, Fitch J, Dietrich W, Body S, Murkin J, Nadel A: Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004;44:1143-1148.
17. Karkouti K, Wijeysundera DN, Yau TM, Callum JL, Meineri M, Wasowicz M, McCluskey SA, Beattie WS: Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery. Can J Anaesth 2006;53:279-287.
18. Morrow JF, Braine HG, Kickler TS, Ness PM, Dick JD, Fuller AK: Septic reactions to platelet transfusions. A persistent problem. JAMA 1991;266:555-558.
19. Ness P, Braine H, King K, Barrasso C, Kickler T, Fuller A, Blades N: Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 2001;41:857-861.
20. Yomtovian R, Lazarus HM, Goodnough LT, Hirschler NV, Morrissey AM, Jacobs MR: A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 1993;33:902-909.
21. Fries D, Haas T, Velik-Salchner C, Lindner K, Innerhofer P: Gerinnungsmanagement beim Polytrauma. Anaesthesist 2005;54:137-144.
22. Görlinger K: Coagulation management during liver transplantation. Hämostaseologie 2006;26(suppl 1):S64-S75.
23. Hartmann M, Sucker C, Boehm O, Koch A, Loer S, Zacharowski K: Effects of cardiac surgery on hemostasis: Transfus Med Rev 2006;20:230-241.
24. Paparella D, Brister SJ, Buchanan MR: Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004;30:1873-1881.
25. Schoechl H: Coagulation management in major trauma: Hämostaseologie 2006;26(suppl 1):S50-S55.
26. Brilakis ES, Banerjee S, Berger PB: Perioperative management of patients with coronary stents. J Am Coll Cardiol 2007;49:2145-2150.
27. Bundesärztekammer: Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten, 3., überarbeitete Aufl. Köln, Deutscher Ärzte-Verlag, 2003.
28. Greinacher A, Kiefel V, Klüter H, Kroll H, Pötzsch B, Riess H: Empfehlungen zur Thrombozytentransfusion der Thrombozyten-Arbeitsgruppe der DGTI, GTH und DGHO. Transfus Med Hemother 2006;33:528-543.
29. Jurk K, Kehrel BE: Inherited and acquired disorders of platelet function. Transfus Med Hemother 2007;34:6-19.
30. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W: An audit of red cell and blood product use after the institution of thromoelastometry in a cardiac intensive care unit. Transfus Med 2006;16:31-39.
31. Avidan MS, Alcock EL, Da Fonseca J, Ponte J, Desai JB, Despotis GJ, Hunt BJ: Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004;92:178-186.
32. Despotis GJ, Joist JH, Goodnough LT: Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997;43:1684-1696.
33. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA: Throboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999;88:312-319.
34. Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM: Cost reduction of perioperative coagulation management in cardiac surgery: value of 'bedside' thrombelastography (ROTEM). Eur J Cardiothorac Surg 2007;31:1052-1057.
35. Klouche M: Diagnostic methods for platelet function analysis. Transfus Med Hemother 2007;34:20-32.
36. Asaf T, Reuveni H, Yermiahu T, Leiberman A, Gurman G, Porat A, Schlaeffer P, Shifra S, Kapelushnik J: The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy. Int J Pediatr Otorhinolaryngol 2001;61:217-222.
37. Dzik WH: Predicting hemorrhage using preoperative coagulation screening assays. Curr Hematol Rep 2004;3:324-330.
38. Eberl W, Wendt I, Schroeder HG: Präoperatives Screening auf Gerinnungsstörungen vor Adenotomie und Tonsillektomie. Klin Pädiatr 2005;217:20-24.
39. Munro J, Booth A, Nicholl J: Routine preoperative testing: a systematic review of the evidence. Health Technol Assess 1997;1:1-62.
40. Velanovich V: The value of routine preoperative laboratory testing in predicting postoperative complications: a multivariate analysis. Surgery 1991;109:236-243.
41. Kitchens CS: To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost 2005;3:2607-2611.
42. Franchini M, Zugni C, Veneri D, Gandini G, Lippi G, Manzato F, Brazzarola P: High prevalence of acquired von Willebrand's syndrome in patients with thyroid diseases undergoing thyroid surgery. Haematologica 2004;89:1341-1346.
43. Homoncik M, Gessl A, Ferlitsch A, Jilma B, Vierhapper H: Altered platelet plug formation in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab 2007;92:3006-3012.
44. Klouche M: Cellular haemostaseology - diagnosis and therapeutic monitoring of inherited and acquired functional platelet disorders. Transfus Med Hemother 2007;34:4-5.
45. Lee A, Chui PT, Aun CS, Lau AS, Gin T: Incidence and risk of adverse perioperative events among surgical patients taking traditional Chinese herbal medicines. Anesthesiology 2006;105:454-461.
46. Michiels JJ, Schroyens W, Berneman Z, van der Planken M: Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin Appl Thromb Hemost 2001;7:113-115.
47. Rott H, Halimeh S, Kappert G, Trobisch H: Most unexpected bleeding complications during or after surgery in German patients occur due to acquired aspirin-related thrombocytopathia or von Willebrands disease. 27th WFH World Congress of Hemophilia; Vancouver, Canada, May 21-25, 2006.
48. Silwer J: von Willebrand disease in Sweden. Acta Paediatr Scand Suppl 1973;238:1-159.
49. Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A, Jude B: Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003;349:343-349.
50. Gerlach R, Tolle F, Raabe A, Zimmermann M, Siegemund A, Seifert V: Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 2002;33:1618-1623.
51. Korte W: Fibrin monomer and factor XIII: a new concept for unexplained intraoperative coagulopathy. Haemostaseologie 2006;26(suppl 1):S30-S35.
52. Wettstein P, Haeberli A, Stutz M, Rohrer M, Corbetta C, Gabi K, Schnider T, Korte W: Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg 2004;99:1564-1569.
53. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, Keita H, Sibony O, Mahieu-Caputo D, Hurtaud-Roux MF, Huisse MG, Denninger MH, de Prost D, for the PPH Study Group: The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007;5:266-273.
54. Koscielny J, Ziemer S, Radtke H, Schmutzler M, Pruss A, Sinha P, Salama A, Kiesewetter H, Latza R: A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004;10:195-204.
55. Koscielny J, Kiesewetter H, von Tempelhoff GF: More on: platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function. J Thromb Hemost 2006;4:1426-1427.
56. Koscielny J, von Tempelhoff GF, Ziemer S, Radtke H, Schmutzler M, Sinha P, Salama A, Kiesewetter H, Latza R: A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 2004;10:155-166.
57. Roschitz B, Thaller S, Koestenberger M, Wirnsberger A, Leschnik B, Fritsch P, Muntean W: PFA-100 closure time in preoperative screening in 500 pediatric patients. Thromb Haemost 2007;98:243-247.
58. Pfanner G, Koscielny J, Pernerstorfer T, Gütl M, Perger P, Fries D, Hofmann N, Innerhofer P, Kneifl W, Neuner L, Schöchl H, Kozek-Langenecker SA: Präoperative Blutungsanamnese. Empfehlungen der Arbeitsgruppe perioperative Gerinnung der Österreichischen Gesellschaft für Anästhesiologie, Reanimation und Intensivmedizin. Anästhesist 2007;56:604-611.
59. Strauß J, Becke K, Schmidt J: Gerinnungsstörungen: Auf die Anamnese kommt es an. Dtsch Ärztebl 2006;103:A1948.
60. Chu MW, Wilson SR, Novick RJ, Stitt LW, Quantz MA: Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004;78:1536-1541.
61. Eisenstein EL, Anstorm KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM: Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007;297:159-168.
62. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A: Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
63. Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, Wong SC, Hong MK: Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with significant risk of bleeding. J Invasive Cardiol 2006;18:162-164.
64. Leong JY, Baker RA, Shah PJ, Cherian VK, Knight JL: Clopidogrel and bleeding after coronary artery bypass graft surgery. Ann Thorac Surg 2005;80:928-933.
65. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, Jeger R, Bader F, Osswald S, Kaiser C, for the BASKETLATE Investigators: Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drugeluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-2591.
66. Pinto Slottow TL, Waksman R: Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis. Catheter Cardiovasc Interv 2007;69:1064-1074.
67. Ray JG, Deniz S, Olivieri A, Pollex E, Vermeulen MJ, Alexander KS, Cain DJ, Cybulsky I, Hamielec CM: Increased blood product use among coronary artery bypass patients prescribed preoperative spirin and clopidogrel. BMC Cardiovasc Disord 2003;3:3.
68. von Heymann C, Redlich U, Moritz M, Sander M, Vargas Hein O, Grubitzsch H, Konertz WF, Spies C: Aspirin and clopidogrel taken until 2 days prior to coronary artery bypass graft surgery is associated with increased postoperative drainage loss. Thorac Cardiovasc Surg 2005;53:341-345.
69. Yende S, Wunderink RG: Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001;29:2271-2275.
70. Favaloro EJ, Facey D; Henniker A: Use of a novel patelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders. Am J Hematol 1999;62:165-174.
71. Mammen EF, Comp PC, Gosselin R, Greenberg C, Hoots WK, Kessler CM, Larkin EC, Liles D, Nugent DJ: PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998;24:195-202.
72. Wuillemin WA, Gasser KM, Zeerleder SS, Lämmle B: Evaluation of a platelet function analyser (PF-100) in patients with a bleeding tendency. Swiss Med Wkly 2002;132:443-448.
73. Favaloro EJ, Kershaw G, Bukuya M, Hertzberg M, Koutts J: Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF:CBA as combined diagnostic strategies. Haemophilia 2001;7:180-189.
74. Lasne D, Fiemeyer A, Chatellier G, Chammas C, Baron JF, Aiach M: A study of platelet functions with a new analyzer using high shear stress (PFA 100) in patients undergoing coronary artery bypass graft. Thromb Haemost 2000;84:794-799.
75. Franchini M: The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol 2007;82:731-735.
76. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA: The predictive value of modified computerized thromoelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003;96:51-57.
77. Fattorutto M, Pradier O, Schmartz D, Ickx B, Barvais L: Does the platelet function analyser (PFA-100) predict blood loss after cardiopulmonary bypass? Br J Anaesth 2003;90:692-693.
78. Hertfelder HJ, Bös M, Weber D, Winkler K, Hanfland P, Preusse CJ: Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting. Semin Thromb Hemost 2005;31:426-440.
79. Gum PA, Kottke-Marchant K, Poggio ED, Gurm H, Welsh PA, Brooks L, Sapp SK, Topol EJ: Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001;88:230-235.
80. Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ: A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:961-965.
81. Chakroun T, Gerotziafas G, Robert F, Lecrubier C, Samama MM, Hatmi M, Elalamy I: In vitro aspirin resistance detected by PFA-100® closure time: pivotal role of plasma von Willebrand factor. Br J Haematol 2004;124:80-85.
82. Niggemeier M: Diagnostik der Thrombozytenfunktion unter Zusatz der Glykoprotein-IIb/IIIa-Rezeptorantagonisten Tirofiban - Vergleich der «Point of Care» Verfahren Thrombelastographie, Impedanzaggregometrie und «Platelet Function Analyser» (PFA-100) bei verschiedenen Tirofibankonzentrationen. Dissertation Heinrich-Heine-Universität Düsseldorf 2004. http://docserv.uniduesseldorf.de/servlets/ DocumentServlet?id = 2944.
83. Geiger J, Teichmann L, Grossmann R, Aktas B, Steigerwald U, Walter U, Schinzel R: Monitoring of clopidogrel action: comparison of methods. Clin Chem 2005;51:957-965.
84. Grau AJ, Reiners S, Lichy C, Buggle F, Ruf A: Platelet function under aspirin, clopidogrel, and both after ischemic stroke: a case-crossover study. Stroke 2003;34:849-854.
85. Mani H, Linnemann B, Luxembourg B, Kirchmayr K, Lindhoff-Last E: Response to aspirin and clopidogrel monitored with different platelet function methods. Platelets 2006;17:303-310.
86. Calatzis A, Theisen F, Reininger AJ, Spannagl M: Monitoring of clopidogrel using multiple electrode aggregometry. Blood 2006;108:A883.
87. Calatzis A, Rahe-Meyer N, Theisen F, Spannagl M: Erfassen der Wirkungen von Aspirin und Clopidogrel durch Multiple Elektroden Aggregometrie. Deutscher Anästhesiekongress 2007, Hamburg, 5.-8. Mai 2007: PO 4.6.1.
88. Ivandic BT, Schlick P, Staritz P, Kurz K, Katus HA, Giannitsis E: Determination of clopidogrel resistance by whole blood platelet aggregometry and inhibitors of the P2Y12 receptor. Clin Chem 2006;52:383-388.
89. Mueller T, Dieplinger B, Poelz W, Calatzis A, Haltmayer M: Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate® analyzer - comparison with two flow cytometric methods. Thromb Res 2007;4:DOI 10.1016/j.thromres.2007.03.022.
90. Sucker C, Kurt M, Lithmathe J, Feindt P, Zotz RB, Scharf RE: High-prevalence of prolonged closure times in the presence of aortic-valve stenosis: association with perioperative transfusion requirements. Transfus Med Hemother 2006;33(suppl 1):19.
91. Hayward CP, Harrison P, Cattaneo M, Ortel TL, Rao AK, for the Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis: Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006;4:312-319.
92. Karger R, Donner-Banzhoff N, Müller HH, Kretschmer V, Hunik M: Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history - a systemic review and metaanalysis. Platelets 2007;18:249-260.
93. Calatzis A, Witwer B, Krueger: A new approach to platelet function analysis in whole blood - the Multiplate analyser. Platelets 2004;15:479-517.
94. Toth O, Calatzis A, Penz S, Losonczy H, Siess W: Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006;96:781-788.
95. Jambor C, Weber C, Gerhardt K, Preibisch D, Zwißler B: Point of care measuring of platelet aggregation with the novel impedance aggregometer Multiplate - the optimal preanalytical conditions required. Deutscher Anästhesiekongress 2007, Hamburg, 5.-8. Mai 2007: PO 4.6.8.
96. Rahe-Meyer N, Gilde I, Calatzis A: Multiple electrode aggregometry is a predictive marker of transfusion requirements during open heart surgery. Hämostaseologie 2006;26:A78.
97. Rahe-Meyer N, Winterhalter M, Boden A, Solomon C, Weilbach C, Piepenbrock S, Calatzis A: Veränderungen der Thrombozytenaggregation im Vollblut während aotokoronaren Bypass-Operationen: Einfluss der Stimulantien. Deutscher Anästhesiekongress 2007, Hamburg, 5.-8. Mai 2007: PO 4.6.6.
98. Calatzis A, Spannagl M, Loreth R: Multiplate® platelet function analysis - application and interpretation. 2007. www.multiplate.net.
99. Seyfert UT, Haubelt H, Vogt A, Hellstern P: Variables influencing Multiplate whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 2007;18:199-206.
100. Calatzis A, von Pape KW, Reininger AJ, Theisen F, Spannagl M: Prevalence of aspirin non-response in out-patients and in-patients as determined by multiple electrode aggregometry. Blood 2006;108:A879.
101. Von Pape KW, Dzijan-Horn M, Bohner J, Spannagl M, Weisser H, Calatzis A: Control of aspirin effect in chronic cardiovascular patients using two whole blood platelet function assays: PFA-100 and multiple electrode aggregometry. 36th Hemophilia Symposium 2005, Hamburg.
102. Kalb M, Scharbert G, Kress HG, Marschalek C, Kozek S: Monitoring of the reversing effect of desmopression on cyclooxygenase-I-induced platelet inhibition. Anesthesiology 2005;103:A394.
103. Wittmann G, Romann A, Conell B, Becker G, Calatzis A, Schramm W: Functional quality control of platelet concentrates using multiple electrode aggregometry. 50th Annual Meeting of the Society of Thrombosis and Haemostasis Research 2006, Basel, February 15-18, 2006: P363.
104. Poston R, Gu J, Manchio J, Lee A, Brown J, Gammie J, White C, Griffith BP: Platelet function tests predict bleeding and thrombotic events after offpump coronary bypass grafting. Eur J Cardiothorac Surg 2005;27:584-591.
105. Inglott S, Burgess C, Liesner R, Khair K: The evaluation of impedance aggregometry to measure response to ristocetin in children with type I von Willebrand disease pre and post intranasal DDAVP: Haemophilia 2006;12(suppl 2):30 (PO 903).
106. Görlinger K, Jambor C, Hanke A, Adamzik M, Hartmann M, Rahe-Meyer N: Thrombelastometry and impedance aggregometry based algorithm for coagulation management in cardiac surgery. Intensive Care Med 2007;33:(accepted for publication).
107. Calatzis A, Fritzsche P, Calatzis A, Kling M, Hipp R, Stemberger A: roTEG Coagulation Analyzer - Ein neues System zur intraoperativen Bedside-Gerinnungsdiagnostik. Anaesthesist 1995;44:491.
108. Hartert H: Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr 1948;26: 577-583.
109. Calatzis A, Fritzsche P, Calatzis A, Kling M, Hipp R, Stemberger A: A comparison of the technical principle of the roTEG Coagulation Analyser and conventional thrombelastographic systems. Ann Hematol 1996;72(suppl 1):142-146.
110. Lang T, von Depka M: Possibilities and limitations of thrombelastometry/graphy. Hämostaseologie 2006;23(suppl 1):S20-S29.
111. Kettner SC, Panzer OP, Kozek SA, Seibt FA, Stoiser B, Kofler J, Locker GJ, Zimpfer M: Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery. Anesth Analg 1999;89:580-584.
112. Lang T, Toller W, Gütl M, Mahla E, Metzler H, Rehak P, März W, Halwachs-Baumann G: Different effects of abciximab and cytochalasin D on clot strength in thrombelastography. J Thromb Haemost 2004;2:147-153.
113. Görlinger K, Lier H, Vorweg M: Diagnose-Algorithmus der «Essener Runde» - Thrombelastometrie mittels ROTEM®. 2006. www.essener-runde.de.
114. Görlinger K: ROTEM® - Erweitertes perioperatives Gerinnungsmanagement. J Anästh Intensivbeh 2005;12:53-58.
115. Görlinger K: Klinischer Stellenwert der Point of Care Diagnostik bei akuter Blutung. Deutscher Anästhesiekongress 2006, Leipzig, 17.-20. Mai 2006: H-102.3.
116. Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B: Validation of rotational thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006;4:411-416.
117. Duchemin G, Kiss G, Gueret G, Rossignol B, Corre O, Kerautret P, Blouch MT, Abgrall JF, Görlinger K, Arvieux: Difference between MCFExTEM and MCF-FibTEM (ROTEM) and platelet activity after cardiopulmonary bypass. Eur J Anaesth 2006;23(suppl 37):85.
118. Mittermayr M, Margreiter J, Velik-Salchner C, Klingler A, Streif W, Fries D, Innerhofer P: Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (ROTEM®): an in vitro study. Br J Anaest 2005;95:310-316.
119. Cho KH, Woo S, Hur CH, Sung KS, Kim MC: Comparative study of heparinase treated activated clotting time with heparinase treated thrombelastography for detecting residual heparin effects following cardiopulmonary bypass. Korean J Anesthesiol 1995;29:850-857.
120. Görlinger K, Hanke A, Kottenberg-Assenmacher E, Herold U, Hartmann M: ROTEM®-basiertes Gerinnungsmanagement bei einem 75 Jahre alten Patienten mit Aortenbogenersatz bei Typ AAortendissektion. Deutscher Anä sthesiekongress 2007, Hamburg, 5.-8. Mai 2007: PO 4.6.8.
121. Görlinger K, Jambor C, Hanke A, Kottenberg-Assenmacher E, Adamzik M, Hartmann M, Rahe-Meyer N: ROTEM®- and Multiplate®-basierter Algorithmus zum Point-of-Care-Gerinnungsmanagement in der Herzchirurgie. Deutscher Anästhesiekongress 2007, Hamburg, 5.-8. Mai 2007: PO 4.6.3.
122. Dirkmann D, Hanke AA, Görlinger K, Peters J: Influence of hypothermia and acidosis on whole blood coagulation studied by thrombelastometry. Anesthesiology 2007;107:A546.
123. Mousa SA, Forsythe MS: Comparison of the effect of different platelet GPIIb/IIIa antagonists on the dynamics of platelet/fibrin-mediated clot strength induced using thrombelastography. Thromb Res 2001;104:49-56.
124. Spiess BD, Tuman KJ, McCarthy RJ, DeLaria GA, Schillo R, Ivankovich AD: Thrombelastography as an indicator of post-cardiopulmonary bypass coagulopathies. J Clin Monitoring Computing 1987; 3:1387-1397.
125. Lösche W, Reinhöfer M, Macholdt C, Franke U, Brauer M, Barz D, Reinhart K, Marx G: Use of ROTEM® thrombelastometry to monitor peri-operative haemostasis in patients with on-pump cardiac surgery. Intensivmedizin 43(suppl 1):23-24.
126. Reinhöfer M, Lösche W, Marx G, Barz D: Perioperative haemostatic management - thrombelastometry in cardiac surgery. Transfus Med Hemother 2006;33(suppl 1):20.
127. Görlinger K, Herold U, Jakob H, Hanke AA: ROTEM-based coagulation management in acute type A aortic dissection: medical and economical aspects. J Anäst Intensivbeh 2007;14:(accepted for publication).
128. Hanke AA, Herold U, Jakob H, Görlinger K: Rotational thrombelastometry based coagulation management in acute type A aortic dissection. Anesthesiology 2007;107:A544.
129. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E: Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005;100:1576-1583.
130. Spiess BD, Gillies BS, Chandler W, Verrier E: Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995;9:168-173.
131. Lier H, Kampe S, Schröder S: Rahmenbedingungen für eine intakte Hämostase. Anaesthesist 2007;56:239-251.
132. Wolberg AS, Meng ZH, Monroe DM, Hoffman M: A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma 2004;56:1221-1228.
133. Williams MS, Ng'alla LS: Heparin therapy leads to platelet activation and prolongation of PFA-100 closure time. J Cardiovasc Pharmacol Ther 2005;10:273-280.
134. Jordan A, David T, Homer-Vanniasinkam S, Graham A, Walker P: The effects of margination and red cell augmented platelet diffusivity on platelet adhesion in complex flow. Biorheology 2004;41:641-653.
135. Valeri CR, Cassidy G, Pivacek LE, Ragno G, Lieberthal W, Crowley JP, Khuri SF, Loscalzo J: Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 2001;41:977-983.
136. Nuttall GA, Olivier WC, Santrach PJ, Bryant S, Dearani JA, Schaff HV, Ereth MH: Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001;94:773-781.
137. Karkouti K, Yau TM, Rensburg A, McCluskey SA, Callum J, Wijeysundera DN, Beattie WS: The effects of a treatment protocol for cardiac surgical patients with exessive blood loss on clinical outcomes. Vox Sang 2006;91:148-156.
138. Görlinger K, Kiss G, Dirkmann D, Dusse F, Hanke A, Arvieux CC, Peters J: ROTEM®-based algorithm for management of acute haemorrhage and coagulation disorders in trauma patients. Eur J Anaesth 2006;23(suppl 37):84-85.
139. Görlinger K, Dirkmann D, Kiss G, Dusse F, Hanke A, Arvieux CC, Peters J: ROTEM®-based management for diagnosis and treatment of acute haemorrhage during liver transplantation. Eur J Anaesth 2006;23(suppl 37):85.